Portfolio Holdings Detail for ISIN IE0009QS7W62
| Stock Name / Fund | MSCI Wld Hlth US A |
| Issuer | |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | WHCA(EUR) Euronext Amsterdam |
Holdings detail for VRTX
| Stock Name | Vertex Pharmaceuticals Inc |
| Ticker | VRTX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US92532F1003 |
| LEI | 54930015RAQRRZ5ZGJ91 |
Show aggregate VRTX holdings
News associated with VRTX
- ProShares Ultra QQQ Experiences Big Inflow
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra QQQ (Symbol: QLD) where we have detected an approximate $392.3 million dollar inflow -- that's a 7.2% increase week over week in outs - 2025-04-15 15:02:19
- Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce
- Yo-yos are fun for kids. But yo-yo stock markets aren't so fun for grown-up investors. And unfortunately, there's been a lot more down "yo" recently than up "yo." - 2025-04-15 08:45:00
- Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades
- "May you live in interesting times." - 2025-04-12 08:48:00
- We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.
- Contrary to what you might read on social media, Warren Buffett isn't a fan of tariffs. Berkshire Hathaway even recently took the unusual step of issuing a press release refuting social media claims that Buffett applauded President Trump's economic policies. - 2025-04-10 07:52:00
- Arrowstreet Capital Limited Partnership Takes $3.73 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
- Arrowstreet Capital Limited Partnership purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,265 shares of the pharmaceutical company’s stock, valued at approximately $3,731,000. Several other […] - 2025-04-09 08:14:56
- TQQQ, NFLX, GOOG, VRTX: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $480.8 million dollar inflow -- that's a 3.4% increase week over week in - 2025-04-07 15:35:24
- Validea Detailed Fundamental Analysis - VRTX
- Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks - 2025-04-07 12:38:05
- 2 Stocks to Buy if You're Worried About a Recession
- Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things might not go that far, it's still worth planning ahead. - 2025-04-07 09:24:00
- Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $567.00 Price Target at Bank of America
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the pharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside of 16.97% from the company’s […] - 2025-04-02 06:00:47
- Validea Detailed Fundamental Analysis - VRTX
- Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks - 2025-03-28 14:31:33
- Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession
- The economy has been on shaky ground for a while, and President Trump's tariffs and trade wars could finally send it into a recession. That's a big concern for the market these days as consumers have been keeping discretionary spending to a minimum as high costs have created many - 2025-03-28 10:30:00
- Notable ETF Outflow Detected - XLV, DHR, VRTX, SYK
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $702.0 million dollar outflow -- that's a 1.8% decrease - 2025-03-27 16:02:51
- Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) PT at $506.70
- Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong […] - 2025-03-20 06:04:53
- Notable ETF Outflow Detected - IVW, VRTX, FI, GEV
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $392.2 million dollar outflow -- that's a 0.8% decrease week over - 2025-03-19 15:41:35
- 3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
- Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. - 2025-03-17 10:47:00
- AlphaQuest LLC Sells 2,767 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
- AlphaQuest LLC trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 84.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 517 shares of the pharmaceutical company’s stock after selling 2,767 shares during the period. AlphaQuest LLC’s holdings in Vertex Pharmaceuticals were worth $208,000 as […] - 2025-03-17 08:02:56
- 3 Stocks With Ironclad Balance Sheets for Long-Term Stability
- Although sometimes overshadowed by the all-important income statement, the balance sheet can offer essential insights into a company's financial health. It revolves around the balance between a company’s assets and liabilities. It helps assess factors important to overall financ - 2025-03-13 11:22:00
- Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. A number of other equities analysts have also weighed in on VRTX. HC Wainwright reiterated a “buy” rating and issued a $550.00 price target on shares of […] - 2025-03-13 06:26:55
- Rep. Jefferson Shreve Purchases Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
- Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Vertex Pharmaceuticals stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made […] - 2025-03-12 06:04:59
- IVW, AXP, FI, VRTX: ETF Outflow Alert
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $306.8 million dollar outflow -- that's a 0.6% decrease week over - 2025-03-11 15:28:55
- Company News for Mar 11, 2025
- Companies in The News Are: VRTX, TSLA, NVDA, COIN - 2025-03-11 13:22:00
- Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
- When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too. - 2025-03-11 09:31:00
- Where Will Vertex Pharmaceuticals Be in 10 Years?
- The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market - 2025-03-11 08:25:00
- 5 Top Stocks to Buy in March
- 2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements is a mistake. - 2025-03-04 11:15:00
- XLV, SYK, DHR, VRTX: Large Outflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $434.3 million dollar outflow -- that's a 1.1% decrease - 2025-02-21 16:22:43
- Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Hold Rating by StockNews.com
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. VRTX has been the subject of a number of other reports. Scotiabank raised their price objective on Vertex Pharmaceuticals from $433.00 to $450.00 and gave the stock […] - 2025-02-21 06:55:07
- Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
- Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future. - 2025-02-20 14:51:41
- Blue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
- Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceutical company’s stock after selling 2,077 shares during the period. Blue […] - 2025-02-19 09:02:04
- IUSG, ANET, VRTX, PH: ETF Outflow Alert
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P U.S. Growth ETF (Symbol: IUSG) where we have detected an approximate $324.0 million dollar outflow -- that's a 1.5% decrease we - 2025-02-13 15:47:21
- Vertex Pharmaceuticals (NASDAQ:VRTX) Given “Hold” Rating at Needham & Company LLC
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. Other equities analysts have also issued reports about the stock. Citigroup started coverage on shares of Vertex Pharmaceuticals in a research report on Thursday, November 14th. […] - 2025-02-13 09:32:55
MSCI Wld Hlth US A VRTX holdings
| Date | Number of VRTX Shares Held | Base Market Value of VRTX Shares | Local Market Value of VRTX Shares | Change in VRTX Shares Held | Change in VRTX Base Value | Current Price per VRTX Share Held | Previous Price per VRTX Share Held |
|---|
| 2025-04-17 (Thursday) | 44,998 | USD 22,008,522 | USD 22,008,522 | | | | |
| 2025-04-16 (Wednesday) | 44,998 | USD 21,864,078 | USD 21,864,078 | 0 | USD -656,971 | USD 485.89 | USD 500.49 |
| 2025-04-15 (Tuesday) | 44,998 | USD 22,521,049 | USD 22,521,049 | 0 | USD 209,691 | USD 500.49 | USD 495.83 |
| 2025-04-14 (Monday) | 44,998 | USD 22,311,358 | USD 22,311,358 | 0 | USD 522,426 | USD 495.83 | USD 484.22 |
| 2025-04-11 (Friday) | 44,998 | USD 21,788,932 | USD 21,788,932 | 0 | USD 392,833 | USD 484.22 | USD 475.49 |
| 2025-04-10 (Thursday) | 44,998 | USD 21,396,099 | USD 21,396,099 | 0 | USD -306,436 | USD 475.49 | USD 482.3 |
| 2025-04-09 (Wednesday) | 44,998 | USD 21,702,535 | USD 21,702,535 | 0 | USD 446,830 | USD 482.3 | USD 472.37 |
| 2025-04-08 (Tuesday) | 44,998 | USD 21,255,705 | USD 21,255,705 | 0 | USD -98,546 | USD 472.37 | USD 474.56 |
| 2025-04-07 (Monday) | 44,998 | USD 21,354,251 | USD 21,354,251 | 0 | USD -2,700 | USD 474.56 | USD 474.62 |
| 2025-04-04 (Friday) | 44,998 | USD 21,356,951 | USD 21,356,951 | 0 | USD -399,132 | USD 474.62 | USD 483.49 |
| 2025-04-02 (Wednesday) | 44,998 | USD 21,756,083 | USD 21,756,083 | 0 | USD -56,248 | USD 483.49 | USD 484.74 |
| 2025-04-01 (Tuesday) | 44,998 | USD 21,812,331 | USD 21,812,331 | 0 | USD -3,599 | USD 484.74 | USD 484.82 |
| 2025-03-31 (Monday) | 44,998 | USD 21,815,930 | USD 21,815,930 | 0 | USD -354,135 | USD 484.82 | USD 492.69 |
| 2025-03-28 (Friday) | 44,998 | USD 22,170,065 | USD 22,170,065 | 0 | USD -443,680 | USD 492.69 | USD 502.55 |
| 2025-03-27 (Thursday) | 44,998 | USD 22,613,745 | USD 22,613,745 | 0 | USD 102,146 | USD 502.55 | USD 500.28 |
| 2025-03-26 (Wednesday) | 44,998 | USD 22,511,599 | USD 22,511,599 | 0 | USD -394,183 | USD 500.28 | USD 509.04 |
| 2025-03-25 (Tuesday) | 44,998 | USD 22,905,782 | USD 22,905,782 | 530 | USD 149,728 | USD 509.04 | USD 511.74 |
| 2025-03-24 (Monday) | 44,468 | USD 22,756,054 | USD 22,756,054 | 0 | USD 379,756 | USD 511.74 | USD 503.2 |
| 2025-03-21 (Friday) | 44,468 | USD 22,376,298 | USD 22,376,298 | 0 | USD -310,386 | USD 503.2 | USD 510.18 |
| 2025-03-20 (Thursday) | 44,468 | USD 22,686,684 | USD 22,686,684 | 0 | USD -104,055 | USD 510.18 | USD 512.52 |
| 2025-03-19 (Wednesday) | 44,468 | USD 22,790,739 | USD 22,790,739 | 0 | USD 12,895 | USD 512.52 | USD 512.23 |
| 2025-03-18 (Tuesday) | 44,468 | USD 22,777,844 | USD 22,777,844 | 0 | USD -68,036 | USD 512.23 | USD 513.76 |
| 2025-03-17 (Monday) | 44,468 | USD 22,845,880 | USD 22,845,880 | 0 | USD 399,768 | USD 513.76 | USD 504.77 |
| 2025-03-14 (Friday) | 44,468 | USD 22,446,112 | USD 22,446,112 | 0 | USD 82,265 | USD 504.77 | USD 502.92 |
| 2025-03-13 (Thursday) | 44,468 | USD 22,363,847 | USD 22,363,847 | 0 | USD 333,510 | USD 502.92 | USD 495.42 |
| 2025-03-12 (Wednesday) | 44,468 | USD 22,030,337 | USD 22,030,337 | 0 | USD 314,834 | USD 495.42 | USD 488.34 |
| 2025-03-11 (Tuesday) | 44,468 | USD 21,715,503 | USD 21,715,503 | 0 | USD -518,942 | USD 488.34 | USD 500.01 |
| 2025-03-10 (Monday) | 44,468 | USD 22,234,445 | USD 22,234,445 | 0 | USD 521,165 | USD 500.01 | USD 488.29 |
| 2025-03-07 (Friday) | 44,468 | USD 21,713,280 | USD 21,713,280 | -1,063 | USD -671,581 | USD 488.29 | USD 491.64 |
| 2025-03-05 (Wednesday) | 45,531 | USD 22,384,861 | USD 22,384,861 | | | | |
| 2024-11-12 (Tuesday) | 62,091 | USD 30,424,590 | USD 30,424,590 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of VRTX by for IE0009QS7W62
Show aggregate share trades of VRTX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-03-25 | BUY | 530 | | | 509.040* | | 503.62 |
| 2025-03-07 | SELL | -1,063 | | | 488.290* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of VRTX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-04-17 | 149,589 | 55 | 338,011 | 44.3% |
| 2025-04-16 | 296,624 | 187 | 513,400 | 57.8% |
| 2025-04-15 | 254,367 | 709 | 363,551 | 70.0% |
| 2025-04-14 | 286,886 | 46 | 453,969 | 63.2% |
| 2025-04-11 | 272,756 | 140 | 520,294 | 52.4% |
| 2025-04-10 | 640,822 | 391 | 911,548 | 70.3% |
| 2025-04-09 | 482,189 | 746 | 1,053,001 | 45.8% |
| 2025-04-08 | 634,793 | 1,461 | 842,262 | 75.4% |
| 2025-04-07 | 567,573 | 635 | 949,414 | 59.8% |
| 2025-04-04 | 584,698 | 132 | 1,070,553 | 54.6% |
| 2025-04-03 | 368,659 | 84 | 721,990 | 51.1% |
| 2025-04-02 | 208,868 | 17 | 375,506 | 55.6% |
| 2025-04-01 | 251,381 | 110 | 429,278 | 58.6% |
| 2025-03-31 | 352,982 | 405 | 666,276 | 53.0% |
| 2025-03-28 | 228,149 | 96 | 514,907 | 44.3% |
| 2025-03-27 | 151,964 | 49 | 396,868 | 38.3% |
| 2025-03-26 | 194,188 | 12 | 377,205 | 51.5% |
| 2025-03-25 | 186,314 | 36 | 330,792 | 56.3% |
| 2025-03-24 | 297,192 | 47 | 493,544 | 60.2% |
| 2025-03-21 | 285,063 | 674 | 478,207 | 59.6% |
| 2025-03-20 | 223,838 | 394 | 359,852 | 62.2% |
| 2025-03-19 | 239,776 | 25 | 424,804 | 56.4% |
| 2025-03-18 | 222,228 | 55 | 376,193 | 59.1% |
| 2025-03-17 | 248,944 | 556 | 369,988 | 67.3% |
| 2025-03-14 | 320,700 | 175 | 522,246 | 61.4% |
| 2025-03-13 | 383,807 | 127 | 587,428 | 65.3% |
| 2025-03-12 | 332,397 | 653 | 481,021 | 69.1% |
| 2025-03-11 | 273,529 | 437 | 501,409 | 54.6% |
| 2025-03-10 | 342,823 | 52 | 597,067 | 57.4% |
| 2025-03-07 | 231,760 | 226 | 414,255 | 55.9% |
| 2025-03-06 | 333,034 | 102 | 506,672 | 65.7% |
| 2025-03-05 | 211,795 | 23 | 333,313 | 63.5% |
| 2025-03-04 | 269,764 | 34 | 456,505 | 59.1% |
| 2025-03-03 | 264,333 | 109 | 460,347 | 57.4% |
| 2025-02-28 | 290,679 | 561 | 483,112 | 60.2% |
| 2025-02-27 | 163,115 | 716 | 318,297 | 51.2% |
| 2025-02-26 | 147,097 | 945 | 243,998 | 60.3% |
| 2025-02-25 | 198,750 | 113 | 440,220 | 45.1% |
| 2025-02-24 | 194,290 | 9 | 399,056 | 48.7% |
| 2025-02-21 | 278,907 | 16 | 442,436 | 63.0% |
| 2025-02-20 | 307,342 | 0 | 562,729 | 54.6% |
| 2025-02-19 | 196,482 | 807 | 643,484 | 30.5% |
| 2025-02-18 | 241,432 | 6,621 | 515,109 | 46.9% |
| 2025-02-14 | 218,396 | 58 | 385,398 | 56.7% |
| 2025-02-13 | 330,307 | 69 | 540,751 | 61.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.